This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Accurus Biosciences, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Richard Zhang: Innovator in Cancer Treatment
Introduction
Richard Zhang is a prominent inventor based in Richmond, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic agents.
Latest Patents
Richard Zhang holds a patent for "CLDN 18.2-specific monoclonal antibodies and methods of use thereof." This patent includes novel anti-CLDN 18.2 antibodies, chimeric antigen receptors (CAR), and methods for detecting or treating ovarian and prostate cancer. His work also encompasses anti-CLDN 18.2 antibody-drug conjugates (ADCs) and bispecific antibodies, showcasing his commitment to advancing cancer therapies. He has 1 patent to his name.
Career Highlights
Richard is currently associated with Accurus Biosciences, Inc., where he continues to push the boundaries of cancer research. His work is instrumental in developing targeted therapies that can improve patient outcomes.
Collaborations
Richard collaborates with various professionals in the field, including his coworker Haishan Lin, to enhance the effectiveness of their research and innovations.
Conclusion
Richard Zhang's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a key figure in the field of medical research. His work continues to inspire advancements in therapeutic strategies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile